ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
ADALIMUMAB (12368Y)
12368Y
Manner of administration:Injection
Restriction (Streamlined authority code: 17713)
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
